Home › Sjogren's Syndrome › Tennessee
Sjogren's Syndrome clinical trials in Tennessee
4 studies for Sjogren's Syndrome are looking for participants at sites in Tennessee.
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621809A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
- Regional One, Memphis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07041099AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Hixson, Hixson
- Artiva Investigational Site Jackson, Jackson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Murfreesboro Medical Clinic Westlawn, Murfreesboro
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06747949From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.